Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kiromic Biopharma Inc (NQ: KRBP ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Sep 13, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 0.6931 (95) Ask (Size) 0.7000 (3) Prev. Close 1.450 Today's Range N/A - N/A 52wk Range 1.430 - 2.890 Shares Outstanding 1,288,235 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Kiromic BioPharma Reports Favorable Results at Six Weeks from Fourth Patient in Deltacel-01 Clinical Trial May 29, 2024 From Kiromic BioPharma, Inc. Via Business Wire Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site May 20, 2024 From Kiromic BioPharma, Inc. Via Business Wire Performance More News Read More KRBP Stock Earnings: Kiromic BioPharma Reported Results for Q1 2024 May 13, 2024 Via InvestorPlace Kiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three Patients April 24, 2024 From Kiromic BioPharma, Inc. Via Business Wire Kiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical Trial April 02, 2024 From Kiromic BioPharma, Inc. Via Business Wire Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial March 19, 2024 From Kiromic BioPharma, Inc. Via Business Wire Life Science Virtual Investor Forum Presentations Now Available for Online Viewing March 08, 2024 From Virtual Investor Conferences Via GlobeNewswire Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024 March 05, 2024 From Virtual Investor Conferences Via GlobeNewswire Kiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial March 01, 2024 From Kiromic BioPharma, Inc. Via Business Wire Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th February 28, 2024 From Kiromic BioPharma, Inc. Via Business Wire Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th February 28, 2024 From Virtual Investor Conferences Via GlobeNewswire Results from First Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two Months February 14, 2024 From Kiromic BioPharma, Inc. Via Business Wire Kiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung Cancer January 29, 2024 From Kiromic BioPharma, Inc. Via Business Wire Kiromic BioPharma Reports Favorable Early Safety and Tolerability Data from First Patient Enrolled in the Phase 1 Deltacel-01 Clinical Trial January 05, 2024 From Kiromic BioPharma, Inc. Via Business Wire Kiromic BioPharma Announces First Patient Dosed in Phase 1 Study Evaluating Deltacel™ for the Treatment of Non-Small Cell Lung Cancer December 14, 2023 From Kiromic BioPharma, Inc. Via Business Wire Kiromic BioPharma Announces Uplisting to OTCQB Market November 16, 2023 From Kiromic BioPharma, Inc. Via Business Wire Kiromic BioPharma Announces Deltacel™ Phase 1 Clinical Trial Enters Patient Recruitment Phase at Beverly Hills Cancer Center November 09, 2023 From Kiromic BioPharma, Inc. Via Business Wire Kiromic BioPharma and Beverly Hills Cancer Center Enter Clinical Trial Agreement October 23, 2023 From Kiromic BioPharma, Inc. Via Business Wire 12 Health Care Stocks Moving In Wednesday's After-Market Session September 13, 2023 Via Benzinga Kiromic BioPharma Common Stock to Begin Trading on the OTC Pink Sheets on September 14 September 13, 2023 From Kiromic BioPharma Via Business Wire Stocks That Hit 52-Week Lows On Tuesday August 01, 2023 Via Benzinga Kiromic BioPharma Welcomes Two New Directors to its Board July 24, 2023 From Kiromic BioPharma, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Friday July 28, 2023 Via Benzinga Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 30, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session June 30, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.